Body composition emerges as a key factor in brain health, according to recent research. Targeted fat reduction and muscle building could be more effective than general weight loss in preventing ...

Annovis Bio (NYSE: ANVS) announced that the first two patients have been enrolled in its pivotal Phase 3 trial evaluating buntanetap for early Alzhe ...

The successful financings come amid a more than two-year stretch when the sector has struggled to attract fresh capital with ...

A new study has found that taking longer to reach the rapid eye movement (REM) stage of sleep is linked to a greater risk of ...

Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found ...

Taking longer to reach the rapid eye movement (REM) stage of sleep could mean you are more likely to develop dementia.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

People’s ability to interpret emotions or focus on performing a task is reduced by short-term exposure to air pollution.

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will participate in a fireside chat at the Oppenheimer 25th Annual ...

InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, announced that it has ...